论文部分内容阅读
目的:对比分析不同血液净化方式对维持性血液透析患者促红细胞生成素的治疗效果.方法:选取2014年1月-2015年4月本院收治的60例维持性血液透析患者,随机分为ABC三组,每组20例患者.A组(HD+HP)采用血液透析+血液灌流、B组(HDF)采用血液透析滤过、C组(HD)采用血液透析,每周进行一次血常规检查,根据贫血情况调整(EPO)用量,检测患者试验前后肾性贫血指标变化.结果:经过三个月的化验治疗,A组(HD+HP)和B组(HDF)血红蛋白水平试验后明显升高,ERI指数下降;C组(HD)ERI指标升高.三组患者均无不良情况发生.结论:(HD+HP)和(HDF)能有效缓解患者微炎症状,改善患者EPO治疗效果,具体治疗效果无明显差异,比(HD)治疗效果显著,(HD+HP)和(HDF)两种治疗方式更具有临床推广价值.“,”objective: comparative analysis of different blood purification way of erythropoietin in patients with maintenance hemodialysis treatment effect. Methods: select 2014 January - April 2015 of 60 patients admitted in our hospital patients with maintenance hemodialysis, randomly divided into ABC three groups, each group of 20 patients. Group A (HD + HP) with hemodialysis + blood perfusion, and group B (HDF) with hemodialysis filtration, group C with hemodialysis (HD), weekly routine blood examination, adjust the dose of (EPO) according to the situation of anemia, test groups of patients before and after the test in patients with renal anemia index changes. Results: the treatment,A group (HD + HP) and group B (HDF) hemoglobin levels increased significantly after experiment, ERI index decreased; group C (HD) ERI index to rise. Three groups of patients are no bad happens. Conclusion: HD + HP) and micro (HDF) can effectively relieve patients inflammation, improve the effect of EPO treatment, no obvious difference was found between specific therapeutic effect, than (HD) treatment effect, (HD + HP) and two treatments (HDF) have clinical popularization value.